Mission
TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE.
Public Charity
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION
AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION, of ALEXANDRIA, VA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $4.7M in revenue, $3.4M in expenses, $41.7M in total assets. 35 publicly reported grants to this organization, totaling roughly $10.1M, appear in IRS filings.
EIN: 464495751
ALEXANDRIA, VA
Single Organization Support
NTEE: E11
Latest filing: 2025
Total Revenue$4.7M
Total Expenses$3.4M
Total Assets$41.7M
Grant Records35
Funding Total$10.1M
Filing Years2021–2025
Where $100 goes at American Association for the Study of Liver Diseases Foundation
How American Association for the Study of Liver Diseases Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$79
Programs
the work itself
$11
Management
running the organization
$10
Fundraising
raising the next dollar
Inside the $79 for programs
$63
Grants and awardsthe aasld foundation raises funds to support the next generation of reesarchers and clinicial expertise in the field of hepatology
$9
Liver leader councilthe liver leader council (LLC) is a dynamic corporate partnership program that engages industry leaders through exclusive benefits, discounts, and strategic summits
$4
Emerging liver scholarsthe emerging liver scholars (els) program, a joint initiative with aasld, inspires medical, surgical, and pediatric residents with potential for academic medicine to pursue hepatology
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS, PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES
$1,208,397
For grant recipient's exempt purposes
$86,650
$7,000
GENERAL SUPPORT
$5,417
INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE, PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS, PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES
$1,197,000
Showing up to 5 of 35 total records — full history available with membership.
Officers & Directors
TRUSTEE
David E Bernstein
TRUSTEE
Jennifer Lai
EXECUTIVE DIRECTOR
Julie Deal End 013125
CHAIR
Kimberly Ann Brown
CHIEF OF STAFF
Marjorie Bynum
CHIEF EXECUTIVE OFFICER
Matthew D'uva
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $4.7M | $3.4M | $41.7M |
| 2024 | $24.3M | $4.1M | $39.5M |
| 2023 | $3.6M | $3.3M | $17.1M |
| 2022 | $1.3M | $2.3M | $16.3M |
| 2021 | $3.0M | $3.8M | $19.5M |
Between 2021 and 2025, reported annual revenue grew from $3.0M to $4.7M (+53%), with total assets most recently reported at $41.7M.
Interactive year-over-year charts and full filing details available with membership.